MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable, net
of allowances of 4...
$253M
(-0.39%↓ Y/Y)
Cash and cash
equivalents
$195M
(-38.87%↓ Y/Y)
Inventories
$153M
(-14.04%↓ Y/Y)
Prepaid expenses
$34M
Other current assets
$16M
Current tax receivable
$2M
(-94.12%↓ Y/Y)
Total current assets
$652M
(-22.29%↓ Y/Y)
Deferred tax assets
$323M
(15.36%↑ Y/Y)
Property, plant and
equipment, net
$144M
(44.00%↑ Y/Y)
Long-term investments
$28M
(3.70%↑ Y/Y)
Other noncurrent
assets
$27M
(-6.90%↓ Y/Y)
Operating lease right of
use assets, net
$26M
(-33.33%↓ Y/Y)
Goodwill and other
intangible assets, net
$2M
(-66.67%↓ Y/Y)
Total assets
$1,201M
(-8.95%↓ Y/Y)
Accumulated deficit
-$243M
(46.48%↑ Y/Y)
Accumulated other
comprehensive loss
-$30M
(16.67%↑ Y/Y)
Total liabilities and
stockholders' deficit
$1,201M
(-8.95%↓ Y/Y)
Total stockholders'
deficit
-$98M
(71.84%↑ Y/Y)
Additional paid-in capital
$112M
(24.44%↑ Y/Y)
Common stock, par value
0.50 per share issued...
$62M
(0.00%↑ Y/Y)
Total liabilities
$1,300M
(-22.06%↓ Y/Y)
Total current
liabilities
$914M
(-2.66%↓ Y/Y)
Long-term debt, less
current portion
$290M
(-7.94%↓ Y/Y)
Accrued litigation
settlement expenses,...
$52M
(-85.75%↓ Y/Y)
Operating lease
liabilities, noncurrent
$22M
(-31.25%↓ Y/Y)
Other noncurrent
liabilities
$21M
(16.67%↑ Y/Y)
Accrued rebates and
product returns
$582M
(3.56%↑ Y/Y)
Accounts payable and
accrued expenses
$250M
(7.76%↑ Y/Y)
Accrued litigation
settlement expenses,...
$42M
(-57.58%↓ Y/Y)
Current portion of
long-term debt
$29M
(61.11%↑ Y/Y)
Operating lease
liabilities, current
$10M
(0.00%↑ Y/Y)
Income taxes payable
$2M
(-71.43%↓ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)